Monoclonal antibodies against extracellular loops of C5aR

Details for Australian Patent Application No. 2003202297 (hide)

International Classifications

Event Publications

3 April 2003 Complete Application Filed

Priority application(s): 60/350,961 25.01.02 US

18 September 2003 Application Open to Public Inspection

Published as AU-B-2003202297

17 November 2005 Application Accepted

Published as AU-B-2003202297

8 December 2005 Application for Amendment

The nature of the amendment is: Amend the invention title to read Anti-C5aR antibodies and uses thereof. Address for service in Australia - FB Rice & Co Level 23 200 Queen MELStreet BOURNE VIC 3000 2004

12 January 2006 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 18 Nov 2005. Address for service in Australia - FB Rice & Co Level 23 200 Queen Street MELBOURNE VIC 3000 2004

4 May 2006 Amendment Made

The nature of the amendment is: Amend the invention title to read Anti-C5aR antibodies and uses thereof 2003269307 Torrent Pharmaceuticals Ltd. The nature of the amendment is: Amend the priority details to patent of addition 2003214534 2004

18 May 2006 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 18 Nov 2005

18 May 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.